Back to the main directory
EarningsReview / Equity
- Revenue and capital beat overshadowed by costs by BNP Paribas Exane
- Huaneng Power Intl (902 HK/600011 CH) by HSBC
- Ringkjøbing Landbobank - Own balance back on growth path by Danske Bank Equity Research
- Rejlers - Strong growth, low operating leverage by Danske Bank Equity Research
- Equinor - The music is about to stop by Danske Bank Equity Research
- Strong fundamentals, weak sentiment by BNP Paribas Exane
- GS E&C (006360 KS) by HSBC
- Fate intertwined with rates by BNP Paribas Exane
- Wrong time to capitulate by BNP Paribas Exane
- Slightly better results, but stormy weather ahead by BNP Paribas Exane
- FQ1''22 postview: Powering ahead by BNP Paribas Exane
- For once not a positive surprise on costs by BNP Paribas Exane
- Q3 results (and 15 questions for management) by BNP Paribas Exane
- Itaú BBA on Grupo Mexico: 3Q21 Miss on Weaker-Than-Expected Results in Mining by Itau
- Sydbank - Adding growth to a non-growth case by Danske Bank Equity Research
- A strong start by BNP Paribas Exane
- Schibsted (Buy, TP: NOK550.00) - Q3 in line with expectations by DnB Markets
- SKF (Hold, TP: SEK220.00) - Challenging conditions by DnB Markets
- Ossur (Buy, TP: DKK51.00) - Recovery slower than expected by DnB Markets
- Austevoll Seafood (Buy, TP: NOK135.00) - Q3 consensus looks high by DnB Markets
- Storebrand (Buy, TP: NOK106.00) - Life is a highway by DnB Markets
- Sparebanken Øst (Hold, TP: NOK54.00) - Mixed quarter by DnB Markets
- Elkem (Hold, TP: NOK37.00) - Not the new normal by DnB Markets
- Neles (Hold, TP: EUR12.50) - No drama by DnB Markets
- Schibsted (Buy, TP: NOK520.00) - Going strong by DnB Markets
- Itaú BBA on Santander Brasil: Decent 3Q21 by Itau
- Kia Corp (000270 KS) by HSBC
- Tinexta - Strong growth ambitions by Edison Investment Research
- Lyko - One of a kind by Danske Bank Equity Research
- Upbeat on 2021 with 2022 focused on investment by BNP Paribas Exane
- Strong growth, though in line with expectations by BNP Paribas Exane
- Pressures as well as progress by BNP Paribas Exane
- Resilient performance against a difficult backdrop by BNP Paribas Exane
- Electrolux - Confidence has just improved ahead of Q4 and 2022 by Danske Bank Equity Research
- 2022 to kick-off with a record backlog by BNP Paribas Exane
- HKEX (388 HK) by HSBC
- Kreate Group - Growth at a reasonable price by Danske Bank Equity Research
- Volume growth slows faster than expected by BNP Paribas Exane
- Kambi - Expanding the customer list is likely by Danske Bank Equity Research
- Hedges expire after 4Q, fortunately by BNP Paribas Exane
- Komplett (Buy, TP: NOK90.00) - Q3 above with positive outlook by DnB Markets
- Novozymes (Sell, TP: DKK420.00) - Guidance catches up to consensus by DnB Markets
- Sampo Oyj (Buy, TP: EUR51.00) - Streamlining continues by DnB Markets
- Demant (Buy, TP: DKK400.00) - Focus on implant recall and OTC by DnB Markets
- Electrolux (Buy, TP: SEK250.00) - In the eye of the storm by DnB Markets
- Peab (Buy, TP: SEK115.00) - Strong Q3, still attractive by DnB Markets
- Axactor (Buy, TP: NOK10.50) - A challenging quarter by DnB Markets
- Pandox (Buy, TP: SEK175.00) - Trending correctly by DnB Markets
- Sparebanken Vest (Hold, TP: NOK103.00) - Superior ROE generator by DnB Markets
- Komplett (Buy, TP: NOK90.00) - Growth set to continue in Q4 by DnB Markets